The Role of β-Blockers in Left Ventricular Dysfunction and Heart Failure

This publication has 43 references indexed in Scilit:

• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
  Journal of the American College of Cardiology, 1995
• Angiotensin-converting enzyme inhibitors and β-blockers in long-term treatment of dilated cardiomyopathy
  American Heart Journal, 1995
• Recovery from Left Ventricular Asynergy in Ischemic Cardiomyopathy following Long-Term Beta Blockade Treatment
  Cardiology, 1994
• The Role of ??-Blockers in the Treatment of Cardiomyopathy and Ischaemic Heart Failure
  Drugs, 1994
• Value of carvedilol in congestive heart failure secondary to coronary artery disease
  The American Journal of Cardiology, 1990
• Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy
  American Heart Journal, 1990
• Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
  Circulation, 1985
• Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial Infarction
  New England Journal of Medicine, 1981
• Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
  Heart, 1975